The Intermountain Healthcare-backed healthcare data software provider's total funding stands at $95m following its series D round.

Redox, a US-based healthcare data integration software developer that counts care provider Intermountain Healthcare has an investor, raised $45m yesterday in a series D round led by investment manager Adams Street Partners.

The round also featured investment firm Avenir and venture capital firms Battery Ventures, .406 Ventures and RRE Ventures.

Founded in 2014, Redox has developed a software platform that enables healthcare organisations to share patient record data efficiently and securely. The proceeds from the round will support product development…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?